These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
184 related articles for article (PubMed ID: 23621618)
1. Pharmacokinetic evaluation of bazedoxifene for the treatment of osteoporosis. Gatti D; Rossini M; Sblendorio I; Lello S Expert Opin Drug Metab Toxicol; 2013 Jul; 9(7):883-92. PubMed ID: 23621618 [TBL] [Abstract][Full Text] [Related]
2. Efficacy and safety of bazedoxifene, a novel selective estrogen receptor modulator for the prevention and treatment of postmenopausal osteoporosis. Palacios S Curr Med Res Opin; 2010 Jul; 26(7):1553-63. PubMed ID: 20429824 [TBL] [Abstract][Full Text] [Related]
3. Conjugated estrogens combined with bazedoxifene: the first approved tissue selective estrogen complex therapy. Sharifi M; Lewiecki EM Expert Rev Clin Pharmacol; 2014 May; 7(3):281-91. PubMed ID: 24580081 [TBL] [Abstract][Full Text] [Related]
4. Bazedoxifene and bazedoxifene combined with conjugated estrogens for the management of postmenopausal osteoporosis. Lewiecki EM Expert Opin Investig Drugs; 2007 Oct; 16(10):1663-72. PubMed ID: 17922629 [TBL] [Abstract][Full Text] [Related]
6. Bazedoxifene: a new selective estrogen receptor modulator for postmenopausal osteoporosis. Genant HK Menopause Int; 2011 Jun; 17(2):44-9. PubMed ID: 21693498 [TBL] [Abstract][Full Text] [Related]
7. Bazedoxifene/conjugated estrogens for menopausal symptom treatment and osteoporosis prevention. Pinkerton JV; Pickar JH; Racketa J; Mirkin S Climacteric; 2012 Oct; 15(5):411-8. PubMed ID: 22853444 [TBL] [Abstract][Full Text] [Related]
8. The evolving role of oral hormonal therapies and review of conjugated estrogens/bazedoxifene for the management of menopausal symptoms. Parish SJ; Gillespie JA Postgrad Med; 2017 Apr; 129(3):340-351. PubMed ID: 28132583 [TBL] [Abstract][Full Text] [Related]
9. Bazedoxifene: a new selective estrogen receptor modulator for the treatment of postmenopausal osteoporosis. Kung AW; Chu EY; Xu L Expert Opin Pharmacother; 2009 Jun; 10(8):1377-85. PubMed ID: 19445558 [TBL] [Abstract][Full Text] [Related]
11. Bazedoxifene + conjugated estrogens in HT for the prevention of osteoporosis and treatment of vasomotor symptoms associated with the menopause. Tella SH; Gallagher JC Expert Opin Pharmacother; 2013 Dec; 14(17):2407-20. PubMed ID: 24093499 [TBL] [Abstract][Full Text] [Related]
12. Bazedoxifene/conjugated estrogens combination for the treatment of the vasomotor symptoms associated with menopause and for prevention of osteoporosis in postmenopausal women. Palacios S; Mejía Ríos A Drugs Today (Barc); 2015 Feb; 51(2):107-16. PubMed ID: 25756066 [TBL] [Abstract][Full Text] [Related]
13. Bazedoxifene when paired with conjugated estrogens is a new paradigm for treatment of postmenopausal women. Pinkerton JV; Stovall DW Expert Opin Investig Drugs; 2010 Dec; 19(12):1613-21. PubMed ID: 21073353 [TBL] [Abstract][Full Text] [Related]
14. Bazedoxifene: a novel selective estrogen receptor modulator for postmenopausal osteoporosis. de Villiers TJ Climacteric; 2010 Jun; 13(3):210-8. PubMed ID: 20184423 [TBL] [Abstract][Full Text] [Related]